Tag - pfizer

 
 

PFIZER

Japan Times
ASIA PACIFIC
Sep 30, 2021
China's vaccine diplomacy drive falters as recipients turn to western shots
In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.
Japan Times
COMMENTARY / World
Sep 29, 2021
Liars may get COVID-19 boosters before those in need
Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.
Japan Times
WORLD
Sep 29, 2021
Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids
A Pfizer spokesperson said the company expects to start and complete its application very soon.
Japan Times
WORLD / Science & Health
Sep 24, 2021
U.S. CDC advisers back COVID-19 booster shots for older people but not for high-risk workers
Beyond older Americans, the committee also recommended the shots for all adults over 50 with underlying conditions, as well as some 18- to 49-year-olds with those conditions.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
WORLD
Sep 20, 2021
Pfizer shot’s protection against hospitalization wanes in study
After four months, Moderna's vaccine was 92% effective against hospitalization, with Pfizer's at 77% and Johnson & Johnson's at 68%.
Japan Times
JAPAN
Sep 14, 2021
Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors
Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.
Japan Times
COMMENTARY / World
Sep 8, 2021
Vaccines versus COVID-19: The great immunity debate
People who don’t want to get vaccinated will grasp at any new piece of information to justify their reluctance — the latest being some pretty good data suggesting that the natural immunity left after recovering from COVID-19 is stronger over the long run than immunity generated by the Pfizer vaccine....
Japan Times
WORLD / Science & Health
Sep 5, 2021
The Moderna vaccine makes more antibodies than Pfizer's. Does it matter?
Subtle differences between the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines are emerging across patient groups over time, but what this all means in the real world is still unclear.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 3, 2021
Vaccine advisers to U.S. FDA face thorny question: Are COVID-19 boosters needed?
A fierce debate is expected around whether most Americans should get another shot rather than just those at high risk of severe illness.
Japan Times
ASIA PACIFIC
Sep 2, 2021
BioNTech vaccines finally reach Taiwan after heated political wrangling
Taiwan has blamed China, which claims the island as its own territory, for nixing an original order from the German firm earlier this year.
Japan Times
WORLD / Science & Health
Sep 1, 2021
Moderna's shot makes twice as many antibodies as Pfizer's, study says
Moderna's COVID-19 vaccine generated more than double the antibodies of a similar shot made by Pfizer and BioNTech in research that compared immune responses evoked by the two inoculations.
Japan Times
ASIA PACIFIC
Aug 30, 2021
Observers puzzled by delays in China's approval of BioNTech-Pfizer vaccine
Some believe Beijing may be concerned that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than Western ones.
Japan Times
LIFE / Lifestyle
Aug 22, 2021
Here’s how to treat COVID-19 vaccine side effects
There's no guarantee that you'll experience side effects from your COVID-19 vaccination, but it doesn't hurt to be prepared for them anyway.
Japan Times
WORLD
Aug 21, 2021
Pfizer COVID-19 vaccine poised to get full U.S. approval next week
President Joe Biden believes the approval will help woo more Americans to get the shot. Pfizer's vaccine has been in use in the U.S. based on an emergency authorization.
JAPAN
Jul 30, 2021
Health ministry panel approves AstraZeneca’s vaccine for people 40 and over
The panel also backed a proposal to make the shot available to people under age 40 who wish to get AstraZeneca's jab or who are allergic to the ingredients of the mRNA vaccines.
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
WORLD
Jul 22, 2021
Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds
The study reiterated that one shot of the vaccines is not enough for high protection from the highly transmissible variant.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
WORLD / ANALYSIS
Jul 13, 2021
Pfizer bid for booster vaccines premature, experts say, with more data needed
The drugmaker's push for health regulators to authorize a third dose of its COVID-19 shot is not yet backed by evidence, despite the fast-spreading delta variant, vaccine experts said.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji